Clinuvel Pharmaceuticals Ltd. | Key People and Executives
Philippe J. Wolgen
Chief Executive Officer, MD & Director
Stanley R. McLiesh
Non-Executive Chairman
Karen Agersborg
Independent Non-Executive Director
Willem A. Blijdorp
Independent Non-Executive Director
Brenda Mary Shanahan
Independent Non-Executive Director
Philippe J. Wolgen
Chief Executive Officer, MD & Director
Darren M. Keamy
Chief Financial Officer & Secretary
Dennis J. Wright
Chief Scientific Officer
Stanley R. McLiesh
Non-Executive Chairman
Karen Agersborg
Independent Non-Executive Director
Willem A. Blijdorp
Independent Non-Executive Director
Brenda Mary Shanahan
Independent Non-Executive Director
| Address |
15 Queen Street
Melbourne Victoria (VIC) 3000
Australia
|
|
Employees
|
- |
| Website |
http://www.clinuvel.com |
| Updated |
07/08/2019 |
| Clinuvel Pharmaceuticals Ltd. is a global biopharmaceutical company. It engages in the the development of SCENESSE, its proprietary photoprotective drug. It also offers drugs for the treatment of various skin disorders. |
